Clinical Study

Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Table 2

Baseline characteristics and clinical variables for all 36 patients.

Characteristic š‘ (%)

Age (years)
ā€ƒMedian (range)60 (46ā€“79)
Sex
ā€ƒFemale10 (28%)
ā€ƒMale26 (72%)
Raceā€ƒ
ā€ƒCaucasian22 (61%)
ā€ƒAfrican-American12 (33%)
ā€ƒOther2 (5%)
Performance status (ECOG)
ā€ƒ08 (22%)
ā€ƒ126 (72%)
ā€ƒ22 (6%)
Prior chemo-radiotherapy
ā€ƒNo1 (3%)
ā€ƒYes35 (97%)
Sites of metastasis
ā€ƒLungā€ƒ21 (58%)
ā€ƒLiver2 (6%)
ā€ƒOther6 (17%)
Treatment cycles administered
ā€ƒMedian (range)4 (0ā€“24)

Percentages may not sum up to 100 due to rounding.
Multiple sites of metastasis may have occurred in the same patient.